SCYNEXIS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.55 USD | +7.64% |
|
+9.93% | -30.49% |
Chart calendar SCYNEXIS, Inc.
4439fc9e61d5d1dc79a.chsexX5ukOtOLjs253dEYV0kiwhaixGNvYHKH7MuD_0.HnR9ky5e0bkiYgJZhjwOKxVz2FwP2yTPjbO_bdYffbkway6BEiz9hCxbCw~ab773507f1008273d0294a6bd477b7f9
Upcoming events on SCYNEXIS, Inc.
Past events on SCYNEXIS, Inc.
| 2024-03-28 04:01 pm | Q4 2023 Earnings Release |
| 2024-02-07 11:00 am | Guggenheim Healthcare Talks Biotechnology Conference |
| 2024-01-24 | Advances Against Aspergillosis and Mucormycosis Conference |
| 2023-11-13 05:17 pm | Q3 2023 Earnings Release |
| 2023-10-21 08:35 am | Trends in Medical Mycology Congress - Abstract Number: S08.6 |
| 2023-09-28 01:50 pm | Cantor Global Healthcare Conference |
| 2023-09-12 09:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-14 04:30 pm | Q2 2023 Earnings Release |
| 2023-06-20 12:30 pm | Maxim Group Virtual Healthcare Conference |
| 2023-06-14 09:30 am | Annual General Meeting |
| 2023-05-11 07:00 am | Q1 2023 Earnings Release |
| 2023-04-18 06:00 am | European Congress of Clinical Microbiology and Infectious Diseases - P3402 |
| 2023-04-16 07:48 am | European Congress of Clinical Microbiology and Infectious Diseases |
| 2023-04-16 06:00 am | European Congress of Clinical Microbiology and Infectious Diseases - P2047 |
| 2023-04-16 06:00 am | European Congress of Clinical Microbiology and Infectious Diseases - P2068 |
| 2023-04-16 06:00 am | European Congress of Clinical Microbiology and Infectious Diseases - P2055 |
| 2023-04-16 06:00 am | European Congress of Clinical Microbiology and Infectious Diseases - P2020 |
| 2023-03-31 08:30 am | Q4 2022 Earnings Release |
| 2023-03-30 08:30 am | Business Update Call |
| 2022-11-09 07:30 am | Q3 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,12 0,13 -9.82% | 0,00 0,00 - | 13,2 13,9 -5.24% | 5,09 4,91 3.65% | 140 142 -1.3% | 31,2 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -51,0 -47,0 -8.59% | 0,00 0,00 - | -85,2 -78,7 -8.2% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -48,9 -47,2 -3.7% | -51,1 -47,5 -7.59% | -60,8 -59,8 -1.67% | -85,8 -81,6 -5.14% | 72,7 91,9 -20.93% | -11,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -53,7 -52,0 -3.27% | -58,3 -31,9 -83.08% | -36,0 -29,1 -23.69% | -67,5 -71,3 5.38% | 67,2 83,5 -19.57% | -9,74 |
|
Net income Million USD | Released Forecast Spread | -53,7 -51,9 -3.57% | -55,2 -26,0 -112.08% | -32,9 -26,9 -22.21% | -62,8 -66,6 5.76% | 67,0 83,5 -19.73% | -9,74 |
|
EPS USD | Released Forecast Spread | -9,60 -8,62 -11.41% | -5,15 -1,76 -193.33% | -1,25 -0,99 -26.69% | -1,47 -1,54 4.55% | 1,39 1,53 -8.91% | -0,24 |
| Announcement Date | 11/03/20 | 29/03/21 | 29/03/22 | 31/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,60 1,16 -48.35% | 0,69 1,09 -37.18% | 1,32 1,64 -19.44% | 1,56 2,06 -24.57% | 1,52 1,36 11.96% | 1,13 0,97 16.35% | 131 95,4 37.79% | 1,76 5,89 -70.08% | 5,80 7,65 -24.2% | 0,30 | 4,24 | 13,2 | 13,5 | 0,86 |
|
EBIT Million USD | Released Forecast Spread | -22,3 -20,9 -6.49% | -19,7 -21,3 7.2% | -21,7 -20,0 -8.65% | -21,8 -21,1 -3.47% | -22,5 -18,3 -23.01% | -10,7 -12,1 11.8% | 117 83,5 39.53% | -10,1 -6,95 -45.3% | -23,1 -3,85 -499.4% | -9,79 | -5,97 | 2,52 | 2,15 | -8,52 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -29,2 -21,9 -33.37% | -10,2 -22,0 53.91% | -13,3 -21,4 37.49% | -29,6 -22,0 -34.56% | -14,4 -19,3 25.17% | -33,9 -12,9 -161.83% | 122 83,1 47.13% | -1,76 -7,05 75.09% | -19,4 -3,45 -464.49% | -9,41 | -5,65 | 2,84 | 2,51 | -7,71 |
|
Net income Million USD | Released Forecast Spread | -29,2 -21,6 -35.32% | -5,45 -22,4 75.66% | -13,3 -21,2 37.03% | -29,6 -22,1 -34.05% | -14,4 -19,3 25.17% | -33,9 -12,9 -161.83% | 122 79,8 53.22% | -1,76 -7,05 75.09% | -19,6 -3,45 -468.49% | -9,41 | -5,65 | 2,84 | 2,51 | -7,71 |
|
EPS USD | Released Forecast Spread | -1,05 -0,77 -36.01% | -0,17 -0,75 77.41% | -0,31 -0,59 47.1% | -0,62 -0,50 -24.42% | -0,29 -0,40 28.1% | -0,71 -0,27 -161.03% | 2,46 1,45 69.42% | -0,04 -0,15 72.6% | -0,39 -0,07 -437.93% | -0,19 | -0,12 | 0,03 | 0,03 | -0,16 |
| Announcement Date | 29/03/22 | 12/05/22 | 15/08/22 | 09/11/22 | 31/03/23 | 10/05/23 | 14/08/23 | 13/11/23 | 28/03/24 | - | - | - | - | - |
More events
Past sector events for SCYNEXIS, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SCYX Stock
- Calendar SCYNEXIS, Inc.
